IMPAX Receives Final FDA Approval for Generic Version of Claritin-D 24-Hour
The U.S. Food and Drug Administration has granted final approval to Impax Laboratories' Abbreviated New Drug Application (ANDA) for a generic version of Schering-Plough's Claritin(R)-D 24-Hour Extended Release Tablets, Impax said....To view the full article, register now.
Already a subscriber? Click here to view full article